Ocimum Biosolutions licenses gene expression analysis program to Bioniche Therapeutics Research Center and the University of Ottawa
Ocimum Biosolutions, a provider of innovative bioinformatics solutions and laboratory information management system (Lims), reports that it has licensed Genowiz to Bioniche Life Sciences and to the University of Ottawa, Canada.
Ocimum's CEO Anuradha Acharya remarked, "Bioniche is a forward thinking biopharmaceutical company committed to sustain and advance the clinical development of its drug discovery programme. "University of Ottawa houses one of the most active biological research labs.
"We expect that Genowiz will meet their requirements and also greatly heighten their research work in the field of microarrays.
"We are proud to have such prestigious organiSations in our client list" Genowiz is a gene expression analysis program that has been designed to store, process and visualiSe gene expression data efficiently.
It includes a suite of advanced analysis methods and offers choice for selecting analysis that is appropriate to a researcher's dataset.
Genowiz provides numerous visualisation options to track down intricate correlation in microarray data.
It allows researchers to organise experimental information, quickly and easily import data files, preprocess, normalise, plot, perform cluster analysis, classify, visualise patterns, review gene information, and link analysis results to external tools.
